“Redhead” Gene Variant Boosts Melanoma Risk

People without red hair who possess the variant are also more likely to develop this form of skin cancer, researchers report.

Written byTanya Lewis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

“Chloris - A Summer Rose” by John William GodwardWIKIMEDIA, ART RENEWAL CENTER MUSEUMScientists have long known that people with red hair have a higher risk of developing skin cancer. Now, researchers from the Wellcome Trust Sanger Institute in the U.K. and colleagues have found that people who develop a form of skin cancer and have the melanocortin 1 receptor (MC1R) gene variant—linked with red hair, freckles, and pale skin—harbor a greater number of mutations in their melanoma tumors, the researchers reported today (July 12) in Nature Communications.

“We have known for a while that there is an association between these [genetic] variants that cause red hair and increased risk of melanoma,” study coauthor David Adams of the Wellcome Trust Sanger Institute told The Guardian. “What this really does is show at least a contributing factor to that is more mutations.”

Adams and colleagues analyzed publicly available genetic data from the tumors of more than 400 melanoma patients ranging in age from their mid-40s to about 70. The researchers found that people who carried the MC1R variant had about 42 percent more sun-associated mutations in their tumors.

Ultraviolet (UV) light—like that from the sun—can damage DNA, and previous research suggested a skin pigment found in “redheads” allowed more UV to pass through. But ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies